Form 4: Director Donald Zurbay Receives RSU Grant at Sight Sciences

Director Donald Zurbay was granted 28,261 restricted stock units as part of the Sight Sciences non-employee director compensation program.

Summary

• Director Donald Zurbay received a grant of 28,261 restricted stock units (RSUs) on June 4, 2026.
• The grant is valued at approximately $130,000 based on the closing price on the grant date.
• The RSUs are scheduled to vest on the earlier of June 4, 2027, or the date of the 2027 annual meeting of stockholders.
• Following this transaction, the reporting person beneficially owns 193,613 shares, including vested options and unvested RSUs.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a routine administrative filing regarding director compensation with no material impact on company operations or financial strategy.

Positives

• Alignment of director interests with shareholders through equity-based compensation.
• Standardized compensation practice under the company's established non-employee director program.

Negatives

• Dilutive impact of new equity grants on existing shareholders.

Risks

• Vesting is contingent upon the director's continued service on the board.

Future Outlook

The RSUs will vest on June 4, 2027, or the date of the 2027 annual meeting, provided the director remains in service.

Management Comments

• The grant was made under the Issuer's Non-Employee Director Compensation Program.

Industry Context

StockSavvy.ai notes that equity-based compensation for board members is a standard governance practice in the medical device sector to ensure long-term alignment with corporate performance.

Comparison to Industry Standards

• The use of RSUs for director compensation is consistent with standard practices for mid-cap medical technology companies.
• The grant value of $130,000 is within the typical range for non-employee director annual equity retainers in the healthcare sector.

Corporate Governance

Stakeholder Impact

• Minor dilution for existing shareholders due to the issuance of new equity units.

Next Steps

• Vesting of RSUs on June 4, 2027, or the 2027 annual meeting date.

Key Dates

Keywords

Sight Sciences, SGHT, Form 4, Director Compensation, Insider Transaction, Restricted Stock Units